Table 1.
N: number of individuals and (%) percent of total participants.
| Variables | N | (%) |
|---|---|---|
| Age in Years | ||
| Age Group 1 (18–40) | 25,213 | 50 |
| Age Group 2 (41–60) | 18,529 | 37 |
| Age Group 3 (61–95) | 6742 | 13 |
| Total | 50,484 | 100 |
| Sex | ||
| Female | 36,801 | 73 |
| Male | 13,683 | 27 |
| Total | 50,484 | 100 |
| Race/Ethnicity | ||
| White/Non-Hispanic | 28,408 | 56 |
| Non-White/Non-Hispanic | 8066 | 16 |
| Any Race/Hispanic | 2662 | 5 |
| Any Race/Other Ethnicity | 11,348 | 23 |
| Total | 50,484 | 100 |
| Prescription History | ||
| Epinephrine Autoinjector Prescription | 1246 | 2 |
| Allergy History | ||
| Any History of Allergy | 14,197 | 28 |
| COVID-19 Diagnosis/Positive PCR Test | ||
| Any Before Vaccination 1 | 3797 | 8 |
| Vaccine Manufacturer | ||
| Pfizer | 20,324 | 40 |
| Moderna | 30,160 | 60 |
| Total | 50,484 | 100 |
| Clock Time of Vaccine Administration/Appointment | ||
| Time 1 (6:00–10:59) | 17,254 | 34 |
| Time 2 (11:00–15:59) | 22,367 | 44 |
| Time 3 (16:00–21:59) | 10,863 | 22 |
| Total | 50,484 | 100 |